Gossamer Bio, Inc. — Director's Dealing 2023

Nov 23, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gossamer Bio, Inc. (GOSS)
CIK: 0001728117
Period of Report: 2023-11-20

Reporting Person: Hasnain Faheem (Director, President & CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-11-20	Stock Option (Right to Buy)	$0.838	A	437500	Acquired	2033-11-19	Common Stock (437500)	Direct

Footnotes

F1: 25% of the total number of shares subject to the option will vest on November 20, 2024 and 1/48th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.